Resnick L. M., et al. Cellular-free magnesium depletion in brain and muscle of normal and preeclamptic pregnancy: a nuclear magnetic resonance spectroscopic study. Hypertension. 2004 Sep:44(3):322–6. doi:10.1161/01. HYP.0000137592.76535.8c.
Rubenowitz E., Axelsson G., Rylander R. Magnesium in drinking water and death from myocardial infarction. Am J Epidemiol. l996; 143:456–62.
Sinatra S. T. The Sinatra solution: metabolic cardiology. Laguna Beach, CA: Basic Health Publications, Inc; 2011.
Takaya J., Higashino H., Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res. 2004 Jun; 17(2):126–36.
Touyz R. M. Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med. 2003 Feb — Jun; 24(1–3):107–36. doi:10.1016/S0098-2997(02)00094-8.
Touyz R. M., et al. Effects of low dietary magnesium intake on development of hypertension in stroke-prone spontaneously hypertensive rats: role of reactive oxygen species. J Hypertens. 2002 Nov; 20(11):2221–32.
Альфа-липоевая кислота
Biewenga G. P., Haenen G. R., Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol. 1997 Sep; 29(3):315–31. doi:10.1016/ S0306-3623(96)00474-0.
Femiano F., Scully C. Burning mouth syndrome (BMS): double blind controlled study of alphalipoic acid (thioctic acid) therapy. J Oral Pathol Med. 2002 May; 31(5):267–9. doi:10.1034/j.1600–0714.2002.310503.
Hagen T. M., et al. (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J. 1999 Feb; 13(2):411–8.
Hagen T. M., et al. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci USA. 2002 Feb 19; 99(4):1870–5. doi:10.1073/ pnas.261708898.
Hagen T. M., et al. Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. Ann NY Acad Sci. 2002 Apr; 959:491–507. doi:10.1111/j.1749–6632.2002.tb02119.
Hager K., et al. Alpha-lipoic acid as a new treatment option for Alzheimer type dementia. Arch Gerontol Geriatr. 2001 Jun; 32(3):275–82.
Jia L., et al. Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-alpha-lipoic acid. Invest Ophthalmol Vis Sci. 2007 Jan; 48(1):339–48. doi:10.1167/iovs.06-0248.
Jiang T., et al. Lipoic acid restores age-associated impairment of brain energy metabolism through the modulation of Akt/JNK signaling and PGC1α transcriptional pathway. Aging Cell. 2013 Dec; 12(6):1021–31. doi:10.1111/acel.12127. doi:10.1111/acel.12127.
Kim D. C., et al. Lipoic acid prevents the changes of intracellular lipid partitioning by free fatty acid. Gut Liver. 2013 Mar; 7(2):221–7. doi:10.5009/ gnl.2013.7.2.221.
Li C. J., et al. Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy. Chin Med J (Engl). 2009 Nov 5; 122(21):2580–6.
Liu J., Killilea D. W., Ames B. N. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc Natl Acad Sci U S A. 2002 Feb 19; 99(4):1876–81. doi:10.1073/pnas.261709098.
Liu J, et al. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann NY Acad Sci. 2002 Apr;959:133– 66. doi:10.1111/j.1749–6632.2002.tb02090.x.
Liu J., et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/ DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha- lipoic acid. Proc Natl Acad Sci U S A. 2002 Feb 19; 99(4):2356–61. doi:10.1073/pnas.261709299.
Meydani M., et al. The effect of long-term dietary supplementation with antioxidants. Ann NY Acad Sci. 1998 Nov 20; 854:352–60. doi:10.1111/j.1749–6632.1998.tb09915.
Nyengaard J. R., et al. Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy. Diabetes. 2004 Nov; 53(11):2931–8. doi:10.2337/diabetes.53.11.2931.
Scott B. C., et al. Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic Res. 1994 Feb; 20(2):119–33. doi:10.3109/10715769409147509.
Tappel A., Fletcher B., Deamer D. Effect of antioxidants and nutrients on lipid peroxidation fluorescent products and aging parameters in the mouse. J Gerontol. 1973 Oct; 28(4):415–24. doi:10.1093/geronj/28.4.415. Thornalley P. J. Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Int Rev Neurobiol. 2002; 50:37–7. doi:10.1016/S0074-7742(02)50072-6.
Williamson J. R., et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993 Jun; 42(6):801–13. doi:10.2337/diab.42.6.801. Ziegler D., et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004 Feb; 21(2):114–21. doi:10.1111/j.1464–5491.2004.01109.
Zhou L., et al. α-Lipoic acid ameliorates mitochondrial impairment and reverses apoptosis in FABP3-overexpressing embryonic cancer cells. J Bioenerg Biomembr. 2013 Oct;45(5): 459–66. Epub 2013 Mar 28.
Креатин
Andrews R., et al. The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure. Eur Heart J. 1998 Apr; 19(4):617–22.
Balestrino M., et al. Role of creatine and phosphocreatine in neuronal protection from anoxic and ischemic damage. Amino Acids. 2002; 23(1–3):221–9. doi:10.1007/s00726-001-0133-3.
Broqvist M., et al. Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure — effects of long-term dietary supplementation. Eur Heart J. 1994 Dec;15(12):1641–50. doi:10.1093/ oxfordjournals.eurheartj.a060447.
Ferrante R. J., et al. Neuroprotective effects of creatine in a transgenic mouse model of Huntington’s disease. J Neurosci. 2000 Jun 15;20(12):4389–97. Field M. L. Creatine supplementation in congestive heart failure [letter]. Cardiovasc Res 1996 Jan; 31(1):174–6.
Gordon A., et al. Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res. 1995 Sep; 30(3):413–8.
Klivenyi P., et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med. 1999 Mar; 5(3):347–50. doi:10.1038/6568.
